What Is Cognitive Rehabilitation for nrSPMS? Nonrelapsing secondary progressive multiple sclerosis (nrSPMS) comes with many challenges. One of the biggest can be its impact on your cognition, which ...

A potential new therapy for multiple sclerosis, as doctors say the new treatment has the potential to turn back the hands of time. University of California scientists worked for 10 years on a drug ...

At the joint meeting of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Stephen ...

Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

The nerve damage caused by multiple sclerosis (MS) can disrupt a person’s ability to walk, balance, and even carry out the most basic everyday activities. Staying physically active can improve sleep ...

CombiRx is a randomized clinical trial to determine if the combined use of interferon beta-1a (IFN) and glatiramer acetate (GA) is a measurably better therapy than either agent used individually in ...

Roche (OTCQX:RHHBY) shares closed ~4% higher in Europe on Monday as the maker of Ocrevus multiple sclerosis therapy announced two Phase 3 trial successes for fenebrutinib, its new experimental drug ...

As the standard of care for relapsing-remitting multiple sclerosis (RRMS), high-efficacy therapy (HET) should be started as early as possible after diagnosis. However, there are adverse effects, ...